Danhong Injection in the Treatment of Unstable Angina Pectoris
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT02007187
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 160 participants
- Registry
-
NCT02007187
-
- Other papers using this trial's data
- Efficacy of add-on Danhong injection in patients with unstable angina pectoris: A double-blind, randomized, placebo-controlled, multicenter clinical trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02007187. Randomized; quadruple masking; primary purpose treatment. Start 2013-12 (actual); primary completion 2017-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Danhong Injection in the Treatment of Unstable Angina Pectoris
- Condition
- Unstable Angina Pectoris
- Intervention (Drug)
- Danhong injection
- Intervention (Other)
- Standard medical care
- Intervention (Drug)
- Placebo
- Lead sponsor
- China Academy of Chinese Medical Sciences
- Collaborator
- China Food and Drug Administration
Record details
- Record id
cardio:ct-nct02007187- Content hash
9ea63e5b18ba9ea3fe7b1f9dc78f3079e3b0fea8302aed37d194e7051151a02d